1-5 of 5
Ellen Neylon, NP
Close
Sort by
Journal Articles

Translational Focus on Targeting HDAC6 with Ricolinostat Confirms Potent Activity in Preclinical Models of Lymphoma and a Favorable Toxicity Profile in Patients with Relapsed or Refractory Lymphoma

Jennifer E Amengual, MD, Lichtenstein Renee, Celeste Rojas, Kelly Zullo, MS, Maximilian Lombardo, Emily Lichtenstein, RN, Ellen Neylon, NP, Changchun Deng, MD PhD, Ahmed Sawas, MD, Bijal D Shah, Catherine Wheeler, MD, Simon S Jones, PhD, Owen A. O'Connor, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1280.
https://doi.org/10.1182/blood.V126.23.1280.1280
Published: 2015
Journal Articles

Targeting Epigenetic Operations with HDAC Inhibitor and Hypomethylating Drugs in Combination Exhibit Synergy in Preclinical and Clinical Experiences in Drug Resistant T-Cell Lymphoma (TCL): A Translational Focus on Doublet Development

Owen A. O'Connor, MD PhD, Kelly Zullo, MS, Enrica Marchi, MD PhD, Changchun Deng, MD PhD, Ahmed Sawas, MD, Donald Steven Colbourn, MD, Celeste Rojas, Renee Lichtenstein, Ellen Neylon, NP, Emily Lichtenstein, RN, Michael Smith, RN, Luigi Scotto, PhD, Jennifer E Amengual, MD
Journal: Blood
Blood (2015) 126 (23): 1282.
https://doi.org/10.1182/blood.V126.23.1282.1282
Published: 2015
Journal Articles

The Combination of Brentuximab Vedotin (Bv) and Bendamustine (B) Demonstrates Marked Activity in Heavily Treated Patients with Relapsed or Refractory Hodgkin Lymphoma (HL) and Anaplastic Large T-Cell Lymphoma (ALCL): Results of an International Multi Center Phase I/II Experience

Ahmed Sawas, MD, Joseph M. Connors, MD, John G. Kuruvilla, MD, Celeste Rojas, Renee Lichtenstein, Ellen Neylon, NP, Emily Lichtenstein, RN, Changchun Deng, MD PhD, Jennifer E Amengual, MD, Diego Villa, MDMPH, Michael Crump, MD, Owen A. O'Connor, MD PhD
Journal: Blood
Blood (2015) 126 (23): 586.
https://doi.org/10.1182/blood.V126.23.586.586
Published: 2015
Journal Articles

Development of an Online Patient Decision Aid for Previously Treated Mantle Cell Lymphoma

Thomas W. LeBlanc, MD MA, Robert C Wolf, PharmD, Ellen Neylon, NP, Valerie Caroselli, Katie Deering, Brad Schenkel, MSc
Journal: Blood
Blood (2015) 126 (23): 5634.
https://doi.org/10.1182/blood.V126.23.5634.5634
Published: 2015
Journal Articles

Preliminary Results of An Ongoing Phase I Trial of Oral Belinostat a Novel Histone Deacetylase Inhibitor in Patients with Lymphoid Malignancies,

Jasmine M. Zain, MD, Francine M. Foss, MD, Catherine S. Diefenbach, MD, Daniel Petrylak, MD, Ameet Narwal, Ellen Neylon, NP, RN, BSN, OCN, Poul Knoblauch, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3710.
https://doi.org/10.1182/blood.V118.21.3710.3710
Published: 2011